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Endotherapy of peripancreatic ﬂuid collections is an increasing utilized procedure in interventional endoscopy. The aim of this
paper is to provide a general overview of the topic, highlighting the indications, technique, and important management issues
relating to endoscopic management of the various forms of peri-pancreatic ﬂuid collections.
1.Introduction
Acute pancreatitis is a common clinical problem, with an
incidence of 210,000 per year in the USA [1], and is most
commonly a consequence of biliary tract stones and alco-
hol. There is a wide spectrum of disease severity ranging
from mild self-limiting disease to severe acute pancreatitis
(SAP), an entity characterized by the presence of systemic
and local complications. Local complications include peri-
pancreatic collections, which can result in signiﬁcant mor-
bidity and mortality. Chronic pancreatitis is also a common
problem causing peri-pancreatic collections, in particular
pseudocysts. For many years, surgery was the major modal-
ity used to treat these entities. Endoscopic trans-gastric
treatment of pseudocysts evolved in the late 1970’s [2].
Percutaneous radiologically assisted procedures were also
employed [3, 4] and, with the advent and development of
cross-sectional imaging, were used more frequently. Endo-
scopic trans-gastric or trans-duodenal drainage established a
role for endotherapy in the management of these problems
following the publication of success in a large series [5].
The use of endosonography in the management of peri-
pancreatic collections is a more recent development, but
one that has rapidly evolved since its ﬁrst reported use in
drainage of pancreatic pseudocysts in 1992 [6]. With EUS
assistance, indications for the use of endoscopic therapy
were extended to include pancreatic necrosectomy in 1996
[7].
2. Classiﬁcationof Peri-PancreaticCollections
A consensus conference in 1992 established the currently
accepteddeﬁnitionsofthelocalcomplicationsofpancreatitis
in what is known as the Atlanta Classiﬁcation [8]. Five major
morphological entities were deﬁned—pancreatic necrosis,
acute ﬂuid collections, pancreatic abscess, acute pseudocyst,
and chronic pseudocyst. Pancreatic necrosis features diﬀuse
or focal areas of non-viable pancreatic parenchyma, usual-
ly with associated peri-pancreatic fat necrosis. Acute ﬂuid
collections are peri-pancreatic collections of ﬂuid, located in
or near the pancreas, lacking a wall of surrounding granu-
lation or ﬁbrous tissue, arising more than 4 weeks after an
episode of acute pancreatitis. Pancreatic abscess is a circum-
scribed intra-abdominal area of pus, usually in proximity
to the pancreas, containing little or no pancreatic necrosis.
Acute pseudocyst is a collection of pancreatic juice enclosed
by a wall of ﬁbrous or granulation tissue. An additional en-
tity of organised pancreatic necrosis (OPN), or walled-oﬀ
pancreatic necrosis (WOPN), is frequently referred to in the
literature, although it is not a speciﬁc entity in the Atlanta
Classiﬁcation. This refers to a collection with good sepa-
ration of devitalised (necrotic) tissue within a ﬂuid-ﬁlled
cavity, and an associated ﬁbrous wall lined by granulation
tissue [9], as distinct from pancreatic necrosis that is not well
deﬁned and lacks a wall (Table 1).
These morphological manifestations result from the un-
derlying inﬂammation associated with acute pancreatitis. In2 Gastroenterology Research and Practice
Table 1: Atlanta Classiﬁcation of SAP—pathomorphological enti-
ties.
Entity Features
Pancreatic necrosis Diﬀuse or focal areas of non-viable
pancreatic parenchyma
Pancreatic abscess
Circumscribed intra-abdominal
collection of pus containing little or no
pancreatic necrosis
Acute ﬂuid collection
Fluid collections located in or near the
pancreas, lacking a surrounding wall of
granulation/ﬁbrous tissue
Acute pseudocyst Collection of pancreatic juice surrounded
by wall of granulation/ﬁbrous tissue
the case of acute ﬂuid collections, serous or exudative reac-
tionsdevelopinresponsetoinﬂammationearlyinthecourse
of disease and are not in communication with the pancreatic
ductal system [10]. Acute pseudocysts are a consequence
of inﬂammation-induced pancreatic ductal disruption, with
extravasation of pancreatic juice inducing the formation of a
ﬁbrous wall in an attempt to contain the ﬂuid [8].
3. ClinicalManifestations/Indications
for Intervention
3.1. Mass Eﬀect. All peri-pancreatic collections can cause
symptoms by virtue of their mass eﬀect and potential to
enlarge. Pain and abdominal fullness are common symp-
toms. Compression of adjacent organs like the stomach, du-
odenum, and bile duct can result in early satiety, vomiting,
weight loss, and jaundice [11]. Symptoms resulting from the
mass eﬀect of ﬂuid collections, in particular pseudocysts, are
frequently the precipitant for endoscopic treatment.
3.2. Infection. All peri-pancreatic collections have the poten-
tialtobecomeinfected,spontaneouslythroughtranslocation
of normal gut ﬂora, and via iatrogenic means in the setting
of instrumentation of a previously sterile collection of tissue
or ﬂuid. As expected, enteric gram-negative organisms, in
particular Enterococcus, Pseudomonas,a n dKlebsiella,t e n dt o
be the most commonly implicated [12], although Candida
species are not uncommonly associated [13].
Infected pseudocysts, pancreatic abscesses, and infected
necrosis are all potentially amenable to endoscopic manage-
ment with the aim of removing the infected focus.
3.3. Hemorrhage/Perforation. Hemorrhage is an uncommon
but serious complication of pancreatic ﬂuid collections.
Compression of an adjacent vessel and subsequent erosion
can result in pseudoaneurysm formation, with potential for
rupture and hemorrhage. The most common site for pseu-
doaneurysm formation is the splenic artery. Rupture of an
aneurysm into a pseudocyst or WOPN can result in hem-
osuccus pancreaticus [14]. Perforations of pseudocysts into
the peritoneum and bowel are well described although un-
common potential complications [15, 16].
3.4. Size. Non-randomized data from published series have
identiﬁed pseudocyst size as a signiﬁcant predictor of need
forintervention,withpseudocystsofgreaterthan6cminsize
requiring intervention in more than 2/3 of cases [17]. On the
basis of this, some advocate treatment of cysts greater than
6cm in size, even in the absence of other clinical symptoms.
However, series with long-term follow-up suggest that as-
ymptomatic cysts can usually be managed conservatively,
regardless of size.
4. Therapeutic Modalities
4.1. Surgery. Surgical management has long been considered
the gold-standard for management of peri-pancreatic collec-
tions, and was the main treatment modality for many years,
prior to the availability of less invasive options. In general,
surgical management provides direct access to the peri-
pancreatic collection with multiple means of drainage, at the
cost of being more invasive and universally requiring general
anesthesia. For surgical management of pseudocysts, open
external drainage is now generally not deemed appropriate,
and internal drainage via formation of a cystgastrostomy or
cystenterostomy is the preferred option [18]. Success rates
with resolution of cysts using surgical methods is high,
but with relatively high complication rates in the range of
24–40% [19–22] and mortality of 5.8% [19]. Laparoscopic
approaches have been used more recently, although there
is little data comparing outcomes with the open approach.
These procedures are associated with around a 10% conver-
sion rate, but a much lower complication and mortality rate
of around 12% and 1% respectively [23–27].
4.2.PercutaneousRadiologicalDrainage. Percutaneousdrain-
age of pseudocysts and abscesses is most commonly per-
formed under CT guidance, with either external (direct
puncture of the cyst through the anterior abdominal wall) or
internaldrainage(directpuncturewithplacementofdouble-
pigtailstentstoformacystgastrostomyunderﬂuoroscopicor
endoscopic guidance).
External drainage has a signiﬁcant failure rate, particu-
larly in the setting of abnormal pancreatic ductal anatomy,
and rates of cutaneous ﬁstula formation have been reported
to be as high as 50% in certain settings [28].
With the internal technique, success in catheter place-
ment is usually achievable more than 90% of the time, with
an immediate complication rate of around 6% and a mortal-
ity rate of 1%. Secondary infection with abscess formation is
not uncommon, occurring in around 11% [29]. Complete
resolution of the pseudocyst with this method has been
reported as 88% or more in several small series [30, 31].
4.3. Endoscopic Therapy
4.3.1. Pseudocysts. Reported success rates for endoscopic
treatment of pseudocysts are very high, ranging from 91
to 100% in the published literature [32–34]. Better tech-
nical success rates are achieved with EUS-guided proce-
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4.3.2. Abscess. By the Atlanta Classiﬁcation, a pancreatic ab-
scesscontainsnosolidnecroticmaterial.Whilstthissituation
resultsinhighclinicalsuccessrateswithendoscopicmanage-
ment, such a situation is actually quite uncommon, as the
majority of infected peri-pancreatic ﬂuid collections tend to
be associated with some degree of necrosis [10]. Because of
this, data on outcomes for abscess drainage is limited. What
does appear apparent is that, compared with pseudocyst
drainage, endoscopic management has a lower success rate
and a higher rate of complications. Older retrospective data
suggested no diﬀerence in outcome with pseudocyst and
abscess drainage [35]. In a recent prospective study, the suc-
cess rate for abscess drainage was 80%, with a complication
rateof30%,mainlyintheformofperforation[36].Thisdata
supports a more cautious approach to abscesses compared
with pseudocysts.
4.3.3. Pancreatic Necrosis. The technique of endoscopic ne-
crosectomy for pancreatic necrosis has evolved over the last
10 year. With increased experience, outcomes have signifi-
cantly improved, to the point that this technique has super-
seded other forms of intervention as the ﬁrst-line manage-
ment where technically feasible. Reported rates of successful
resolutionofwalled-oﬀpancreaticnecrosisexceed75%,with
a relatively low mortality rate. In up to 20% or more of cases,
walled-oﬀ necrosis persists despite endoscopic management,
andsurgicalorradiologicalinterventionmaystillberequired
[12, 13]. The most recent data comes from a large multicen-
ter retrospective series of 104 patients examining endoscopic
necrosectomy for symptomatic necrosis [37]. This study re-
ported successful resolution of pancreatic necrosis in 91%,
with a complication rate of 14%.
Certain disease and patient-related factors have been
shown to impart a higher failure rate in endoscopic necro-
sectomy and should inﬂuence decisions regarding the man-
agement modality used. Extension of the collection into the
paracolic gutters, a collection size greater than 15cm, and
patients with comorbid diabetes mellitus have all been asso-
ciated with lower success rates with endoscopic therapy [12].
4.4. Comparison of Therapeutic Modalities. Few studies have
set out to directly compare the therapeutic modalities avail-
able for management of peri-pancreatic ﬂuid collections.
Most of those that have were small in size, and there are no
randomized studies comparing the various techniques.
A large population-based analysis comparing surgical
with percutaneous management of pancreatic pseudocysts
[20] demonstrated signiﬁcant diﬀerences in favor of surgical
management in relation to complications, length of stay (15
days versus 21 days), and inpatient mortality (2.8% versus
5.9%).
Generally, the choice of therapeutic modality employed
depends on the characteristics of the collection, patient
factors, local expertise, and physician preference.
5. Assessment Prior to Endoscopic Therapy
An adequate assessment of the nature and anatomical rela-
tions of peri-pancreatic ﬂuid collections is necessary prior to
endoscopic therapy, in order to maximize success and mini-
mize complication rates.
5.1. Cross-Sectional Imaging. Imaging with CT or MRI pro-
vides important information about the nature of peri-pan-
creatic ﬂuid collections in a non-invasive fashion. Contrast-
enhanced CT scanning is the most commonly employed
technique and is able to provide information on size of the
collection, presence and thickness of a wall, presence of
internal debris, and contrast-enhancement characteristics
that suggest tissue necrosis. Contrast-enhanced, multidetec-
tor row CT scan is the best imaging modality to exclude
alternative diagnoses, assess severity, and identify complica-
tions [38]. Pancreatic MRI is an alternative imaging modal-
ity, with evidence to suggest a greater ability to detect solid
components within a ﬂuid collection and therefore better
distinguish pseudocysts from walled-oﬀ necrosis [39]. This
advantage means that MRI assessment should be strongly
considered as part of the workup of pancreatic ﬂuid collec-
tions prior to endotherapy. The presence of a mature wall is
a prerequisite for endoscopic intervention, and so pre-inter-
vention imaging guides decision-making on the timing and
appropriateness of potential management strategies. MRCP
can provide important details on the relationship of peri-
pancreatic ﬂuid collections to the pancreatic duct and iden-
tify pathology associated with a disconnected pancreatic tail.
If a collection can be demonstrated to communicate with the
PD, endoscopic management may need to address the pan-
creatic ﬁstula, in addition to the cyst itself (see Section 6.3).
5.2. Use of Endosonography. Although utilization of EUS to
assess peri-pancreatic ﬂuid collections is not essential, it has
been demonstrated to provide multiple advantages.
The use of EUS is indicated to visualize and avoid vessels
orvaricesthatmayexistalongthepathoftheneedleorﬁstula
to be created. It is also indicated when a cyst does not have a
bulge into the GI lumen. It has traditionally been considered
that 1cm is the maximum recommended distance between
theGIlumenandthecystcavitywhenconsideringendoscop-
ic therapy.
The addition of an EUS assessment of peri-pancreatic
ﬂuid collections prior to endoscopic intervention can result
in a change in management in up to 1/3 of patients. Changes
can result from alternative diagnoses other than peri-pancre-
atic ﬂuids collections, and identiﬁcation of anatomical and
vascular factors preventing endoscopic management [40].
This is particularly important in patients with portal hy-
pertension, where vessels are more likely to be interposed
between the GI tract and the peri-pancreatic collection [41].
The presence of signiﬁcant solid debris within a collection
can often be seen on EUS, even in settings where radiological
imaging had failed to identify such elements. Such a ﬁnding
suggesting pancreatic necrosis may well change a decision to
intervene in what was previously thought to be a pseudocyst,
duetheriskofconvertingsterilenecrosisintoinfectednecro-
sis.
For these reasons and others, studies have consistently
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EUS. In a randomized trial, EUS use resulted in as much
as a 66% increase in success [42]. The largest randomized
trial comparing the techniques demonstrated a 91% success
ratewithemploymentofEUS,comparedwith72%whennot
used. Most failures without EUS use were due to the non-
bulgingnatureofthecollection.WhenEUSwasusedinthese
cases, drainage was successful [43].
6. Technique
6.1. Pseudocyst Drainage. Pseudocyst drainage is usually
fairly straightforward technically when done on a cyst with
no solid component. The aim is to create a permanent ﬁstula
between the cyst and the adjacent GI tract, typically the
stomach or the duodenum. The location of the ﬁstula should
not matter since the ﬂuid will empty into the GI tract by
pressure eﬀect. We try to avoid the very high stomach as
stents may interfere with the GE junction, although many
times this is an area that is very well visualized with the
endosonoscope and appealing, given that the endoscope is
straight and short.
The technique involves advancing a wire into the cyst.
The cyst cavity can be pierced either with a 19-gauge EUS
needle under EUS guidance or with a needle-knife if not
using EUS. A wire can then be advanced under ﬂuoroscopy
into the cyst, and typically it is seen coiling inside the cyst.
We feel that injection of contrast into the cyst is not always
necessary. We prefer the Boston Scientiﬁc 450cm, 0.035
Superstiﬀ Jagwire, which may counteract the early coiling of
the double-pigtail stent as it is being deployed later in the
procedure. If using the EUS needle, it is important not to
pull the wire back into the needle since there is concern for
shearing a piece of the wire by the sharp needle tip.
The next step after the wire is in place is to dilate the
tract. We prefer to see whether a dilation balloon will be
able to pierce the gastric wall into the cyst and favor the
Hurricane8–10mmbiliarydilationballoon,givenitsﬂexible
tip, and stiﬀ shaft due to the presence of a stylet. If we are
unsuccessful, we then use either the needle-knife with 1-
2mm of the needle out, with ERBE sphincterotomy settings,
or a cystotome (Cystotome, Wilson Cook). The tract is
pierced with the thin sheath and immediately dilated with
the thicker sheath, using 80–100 watts of pure-cut current.
The tract is then balloon-dilated under ﬂuoroscopy to
10mm for 1 minute. Typically after deﬂating the balloon, a
large amount of turbid, yellowish ﬂuid emanates from the
tract.
In our practice, a minimum of three double-pigtail stents
are then placed if possible. It is typically diﬃcult to advance
a 10Fr stent through the endosonoscope lumen, especially if
there are 2 wires in the cyst. In these cases, we either place
7Fr stents or switch the endoscope for a therapeutic, larger-
channel endoscope.
Selection of stent size depends on the size of the pseu-
docyst. For smaller cysts (10cm in diameter), we prefer
10Fr, 4cm stents. For larger cysts, we prefer placing 10Fr,
7cm stents, although there is no data to guide this practice.
Placing a 10Fr double-pigtail stent can be challenging given
the tendency of the stent to recover its shape as soon as it
comes out of the endoscope channel, hence the use of the
Superstiﬀ Jagwire from initial cyst puncture. Care should be
taken to ensure the stent is deployed correctly and does not
migrate into the pseudocyst lumen.
Follow-up at our institution is typically with a CT scan at
4 weeks and a clinic visit for review, with an endoscopic stent
removal procedure shortly thereafter, assuming the cyst has
resolved.Therehasbeenarecentstudythatsupportskeeping
stentsin-situforalongerperiodoftime,withsuperiorresults
obtained with stent durations of up to 2 years [44]. The
pancreatic ductal anatomy also inﬂuences stent duration. If
a disconnected tail is seen, it is likely that the disconnected
pancreas will continue draining into the cyst cavity. To pro-
moteamorematureﬁstulaandpreventearlyclosure,wetend
to leave the stents for a longer time, about three months, in
these cases.
6.2. Necrosectomy. In the ﬁrst session of necrosectomy, our
technique is similar to the one described for pseudocyst
management. The goal at this point is to drain the liquid
component of the cyst. Stents are placed as previously de-
scribed. The second session typically takes place a few days
later. These procedures can be time-consuming, so they are
performed under general anesthesia.
At subsequent sessions, the stents are removed and a
wire is placed in the cyst cavity under ﬂuoroscopy. The
tract is dilated to 16–18mm, and a therapeutic endoscope is
advanced into the cavity guided by the wire. Care is needed
not to over-insuﬄate the cyst cavity with air. The instru-
m e n t ss e l e c t e dt or e m o v en o n - v i a b l em a t e r i a lw i l ld e p e n d
on whether the necrotic debris is semi-solid or solid. For
liqueﬁed or semi-solid debris, irrigation via the jet port is
usually helpful, although suctioning may only clog the chan-
nel if there are large particles. In order to gain the greatest
eﬃciency of solid tissue removal, instruments we use (in
order of preference) are nets, (Nakao-Spider, ConMed; Roth,
US Endoscopy), baskets (Twister, Boston Scientiﬁc), snares,
or biopsy forceps to break large blocks of necrosis. This
choice of instruments is subjective and depends entirely on
physician preference and the nature of the material to be
removed.Thescopeisadvancedintothecavityasmanytimes
as needed to remove as much debris as possible. The stents
are replaced at the end of the procedure.
The procedure is typically repeated 3-4 times, at weekly
intervals, in order to obtain complete clearance of necrotic
tissue. The patient is typically covered with antibiotics.
Although the number of sessions required is highly variable
and dependent on the nature of the cavity and extent of
necrosis, studies examining the issue have found the median
number of session required to be 3, with up to 12 sessions
being required in some cases [12].
6.3. Adjunctive Therapy
6.3.1. Management of the Pancreatic Duct. The etiologies of
pancreatic ﬂuid collections, particularly those that occur in
the setting of acute pancreatitis, are related to disruption to
the pancreatic ductal system. As a sequelae of this, pancreatic
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the pancreatic ductal system with the ﬂuid collection means
that pancreatic glandular secretions have a passage through
which to enter and propagate the collection. If endoscopic
drainage of a collection is performed, pancreatic ﬁstulae are
a cause of potential recurrence. As such, integrity of the
pancreatic duct is a prerequisite for successful endoscopic
therapy in the long term. For this reason, the importance
of appropriate assessment of the anatomical relationship of
the pancreatic duct to the peri-pancreatic collection pri-
or to endoscopic treatment with MRCP or ERCP cannot be
understated. Should a pancreatic ﬁstula be identiﬁed, con-
sideration should be given to performing trans-papillary
drainage. This procedure involves passage of a hydrophilic
guidewire through the pancreatic duct and either into the
collection through the ﬁstula or upstream of the ﬁstulous
tractinthepancreaticduct.Apancreaticsphincterotomyand
placement of a pancreatic stent are then performed. Such
interventionhasbeenshowntoimprovetreatmentoutcomes
in patients undergoing endoscopic transmural drainage of a
pancreatic ﬂuid collection [45]. The duration of pancreatic
stent placement depends upon the time taken for resolution
ofthecollectionandthepresenceofductstricturesorstones,
which may require a prolonged course of stent placement.
Sealing of persistent pancreatic ﬁstula with cyanoacrylate
glue has been described and is a part of the treatment pro-
tocol for managing pancreatic ﬁstulae in certain centers [46].
6.3.2. Nasocystic Drainage. Placement of a nasocystic drain
following initial access into a peri-pancreatic ﬂuid collection
allows for interval access to the collection for interventions
such as lavage and administration of antibiotics. This is of
particular beneﬁt in walled-oﬀ pancreatic necrosis, where
multiple sessions are required to adequately clear necrotic
tissue. Use of the nasocystic catheter to perform lavage with
normal saline in between endoscopic sessions has been
shown to reduce rates of super-infection in this setting [47].
7. Complications of Endotherapy
General complications include severe bleeding and perfora-
tion. Prevention of this requires adequate pre-intervention
assessment of the presence of a mature wall, ensuring close
proximity of the GI wall to the collection, and addressing any
coagulation abnormalities.
Secondary infection prevention requires use of prophy-
lactic antibiotics. We tend to use ciproﬂoxacin for a period of
u pt o7d a y s .
7.1. Pseudocysts. Endoscopic pseudocyst drainage is gener-
ally a safely performed procedure. With current techniques,
experienced operators have perforation rates as low as 1.2%,
with bleeding rates of less than 1%. Perforation appears to
be more common with pseudocysts in the uncinate region of
the pancreas. Migration of stents occurs in less than 1% of
cases. Infection rates are in the region of 5% [48].
7.2.PancreaticNecrosis. Endoscopicnecrosectomyofwalled-
oﬀ pancreatic necrosis is a more involved undertaking and
occurs in a patient population that is usually sicker than
those with pseudocysts. As such, complication rates are
higher, being as high as 26% in the largest studies. The most
common complications are bleeding and perforation, occur-
ring in 54% and 21%, respectively, in the GEPARD study,
with a mortality rate of 7.5% [13]. Given that endoscopic
necrosectomy by deﬁnition involves operation outside the
conﬁnes of the GI tract, air embolism is a potential compli-
cation not seen with other peri-pancreatic ﬂuid collections,
with a rate of 8% [13]. This complication can potentially be
overcome by use of CO2 instead of air for insuﬄation.
8.Recent Advances andFutureDevelopments
8.1. Forward-Viewing EUS Biopsy Capability. The standard
EUS imaging platform currently available on the market for
therapeutic interventions is the curvilinear echoendoscope,
which provides an oblique view of the imaged tissue region.
This results in practical disadvantages in the management
of peri-pancreatic ﬂuid collections as the accessories are
advanced out of the scope tip at an acute angle. The mechan-
ical force of the accessory onto the structure to be targeted
tends to push the scope away from the area of interest, cre-
ating problems with adequate visualization and maintenance
of direction. In addition, the angle of the scope tip that needs
to be maintained for appropriate positioning is often prob-
lematic from an anatomical perspective. A forward-viewing
echoendoscope with a working channel in line with the
scope shaft has been developed to overcome these problems
(Olympus). Although not yet commercially available, the
limited data available on its usefulness in a variety of inter-
ventional procedures is encouraging [49]. It has proven
eﬀectiveinallowingdrainageofpancreaticpseudocystswhen
use of the oblique-viewing echoendoscope has failed for
technical reasons [50].
8.2. Use of SEMS. One drawback of using plastic stents
to maintain the tract between a ﬂuid collection and the
enteric lumen is the tendency of these stents to migrate or
become blocked. Self-expanding metal stents have been used
in an attempt to overcome these problems [51], although
migration may still be an issue. New stent designs with a
larger diameter (20–25mm) have been developed for use in
pancreatic necrosectomy, with the advantage of maintaining
a tract through which an endoscope can pass over multiple
sessions,withouthavingtochangethestentoneachoccasion
[52].
9. Conclusion
Management of the complications of severe acute pancre-
atitis, and peri-pancreatic ﬂuid collections in general, has
come a long way over the last 20 years. The employment
of endoscopic management for these conditions is becoming
more widespread as technologies and techniques continue to
evolve. The available evidence highlights the ﬁrst-line role
for endoscopic management is certain situations, such as
pseudocyst drainage, with increasing support for its utility in
treatment of conditions such as infected pancreatic necrosis,6 Gastroenterology Research and Practice
in the appropriate clinical setting. The role of endoscop-
ic management will continue to be reﬁned as more long-
term data becomes available, and management algorithms
are more solidly established. The need to better deﬁne ev-
idence-based optimal practice, and to develop appropriate
device technology, provides fertile ground for clinical re-
searchers and equipment manufacturers alike in advancing
this cutting-edge area of endoscopy.
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